Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Archive
    • Podcast: NC Health Policy Forum
    • Upcoming Scientific Articles
  • Info for
    • Authors
    • Reviewers
    • Advertisers
    • Subscribers
  • About Us
    • About the North Carolina Medical Journal
    • Editorial Board
  • More
    • Alerts
    • Feedback
    • Help
    • RSS
  • Other Publications
    • North Carolina Medical Journal

User menu

  • My alerts
  • Log in

Search

  • Advanced search
North Carolina Medical Journal
  • Other Publications
    • North Carolina Medical Journal
  • My alerts
  • Log in
North Carolina Medical Journal

Advanced Search

  • Home
  • Content
    • Current
    • Archive
    • Podcast: NC Health Policy Forum
    • Upcoming Scientific Articles
  • Info for
    • Authors
    • Reviewers
    • Advertisers
    • Subscribers
  • About Us
    • About the North Carolina Medical Journal
    • Editorial Board
  • More
    • Alerts
    • Feedback
    • Help
    • RSS
  • Follow ncmj on Twitter
  • Visit ncmj on Facebook
Research ArticlePolicy Forum

Harm Reduction Strategies for the Opiod Crisis

Tessie Castillo
North Carolina Medical Journal May 2018, 79 (3) 192-194; DOI: https://doi.org/10.18043/ncm.79.3.192
Tessie Castillo
advocacy and communications coordinator, North Carolina Harm Reduction Coalition, Raleigh, North Carolina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tswopecastillo@gmail.com
  • Article
  • References
  • Info & Metrics
  • PDF
Loading

Abstract

In order to reduce disease transmission and overdose death resulting from the opioid crisis, North Carolina has recently adopted several harm reduction programs, including community based naloxone distribution and syringe exchange. Additionally, discussions are taking place about safe injection facilities as a way to further reduce the harm of opioids.

Only a decade ago the words “harm reduction” would send many public health officials, law enforcement, and elected representatives scrambling for political cover. Harm reduction had often been controversial because it doesn't subscribe to the abstinence-only curriculum that has long been the main source of teaching about sex and drugs in the United States. Many people now support the idea that condoms are an effective way to prevent pregnancy and disease transmission. They recognize that merely trying to scare or shame people doesn't usually work. Yet with drugs, we continue to fall back to “just say no” messaging. Harm reduction programs that teach practical methods such as clean syringe distribution to lessen mortality or disease transmission associated with drugs are often accused of “sending the wrong message” or “enabling drug use.” But in recent years, the severity of the opioid crisis has led policymakers and the public to be more willing to embrace alternative methods to resolve the problem. Several of these methods have recently been implemented in North Carolina.

In 2013, in response to the wave of opioid-related overdose deaths, the North Carolina General Assembly passed a law expanding the availability of naloxone for lay people. Naloxone is a safe, non-addictive medication that reverses opioid overdose. From August 1, 2013 to February 11, 2018, community based distribution programs across the state handed out over 60,000 overdose prevention kits containing naloxone to people at risk for overdose and their loved ones [1]. During the same time period, people across the state reported using 10,240 of these kits to reverse an overdose [1]. Each kit is accompanied by a short training on how to avoid an overdose, and how to recognize and respond to an overdose should one occur. Additionally, 210 law enforcement departments across the state—about half the total departments—now carry naloxone so that officers and deputies have a tool to use to respond to an overdose [2]. Law enforcement officers had conducted over 800 rescues with naloxone as of February 11, 2018 [2].

In 2016, 3 years after the passage of the original overdose prevention law, North Carolina's state medical director signed a standing order enabling pharmacists to dispense naloxone to anyone at risk for an overdose or anyone who knows someone at risk. As of February 11, 2018, 1,409 pharmacies across the state were active participants in this program [3]. This program allows North Carolinians in need of an overdose prevention kit to walk into any pharmacy and ask for naloxone without a prescription, which greatly expands the medicine's accessibility. Many governmental and non-governmental organizations across North Carolina are also working to encourage pharmacists to be proactive about talking to all patients who fill opioid prescriptions about naloxone, instead of waiting for the patient to ask.

In 2016, North Carolina also legalized another harm reduction program: syringe exchange. Syringe exchange programs distribute sterile syringes to injection drug users, collect used syringes, and offer wraparound services such as HIV testing and linkage to drug treatment programs. Back in the 1980s when the nation was grappling with the AIDS epidemic, many people lost their lives as HIV spread through injection drug use. The very first harm reduction programs began by introducing the concept of syringe exchange. Initially, these programs were met with storms of protests and accusations of enabling. But over 30 years of research, the effectiveness of syringe exchange programs is pretty clear: they significantly reduce the spread of HIV, Hepatitis C, and other bloodborne illnesses among injecting drug users [4, 5]. They remove used syringes from the streets [6], reduce syringe-stick injury to first responders [7], and have even been shown to reduce crime by connecting people with social services such as food banks, employment programs, and health care [8]. Additionally, some studies have demonstrated that people who participate in syringe exchange programs are more likely to seek treatment for drug use than people who do not [9]. As of February 2018, 26 syringe exchange programs exist throughout North Carolina in such diverse locations as bookstores, pawn shops, churches, fire departments, health departments, AIDS services organizations, and drug user unions [10]. During the first year after legalization, the programs distributed over 1 million syringes, administered over 2,600 HIV tests, and referred over 3,500 people to drug treatment programs [11].

North Carolina has adopted many other harm reduction techniques and programming, including medication-assisted treatment, overdose prevention training for people impacted by drug use and first responders, pre-arrest diversion programs that divert low-level drug users from jail to social services, HIV and Hepatitis C testing and linkage-to-care programs, laws that protect people who call 911 to report an overdose from being prosecuted if police find small amounts of drugs on the scene, expansion of substance use treatment programs, and much more. But the latest debate across the country, and to an extent in North Carolina as well, is over safe injection facilities. Safe injection facilities are sites where people can legally consume drugs under staff or medical supervision. They are designed to reduce the incidences of people injecting drugs in public parks, bathrooms, cars, or other public areas, and also to reduce other public harms such as overdose, intoxicated driving, and improper disposal of syringes. Though no sites are currently in operation in the United States, several cities are currently advocating for them and safe injection facilities have been operating in Australia, Canada, and some European countries for many years. As with all new harm reduction initiatives, the sites initially met a wall of criticism about enabling drug use, but today enjoy significant public support [12]. In the United States, San Francisco plans to open its first safe injection facility in the summer of 2018, while other cities such as Philadelphia, Baltimore, and Seattle are debating whether to implement safe injection facilities as well.

Decades of research support the efficacy of harm reduction techniques in reducing disease transmission, saving lives, and even helping people lessen or stop their drug use. In the same sense that taking small, practical steps to improve diet and exercise habits is often more effective than attempting to lose massive amounts of weight very quickly, for many people, taking small steps to reduce the harms of drug use can be more achievable than total abstinence from all drugs. Even in the context of the current opioid crisis, where pharmaceutical-grade drugs may be laced with unknown substances that increase the risk of overdose, there are harm reduction techiques to reduce these risks. Examples include using test strips to detect the presence of high-risk opioids like fentanyl, doing small “test shots” to check the potency of a drug before using it, keeping naloxone on hand, never using alone, and being knowledgeable about local laws that may protect people who call 911 to report an overdose. The goal of harm reduction with regard to drug use is to encourage positive steps toward improving a person's health and wellness, however that person may choose to define it. For some people, that means abstinence from drugs. For others, it means lessening their drug use, managing their drug use, or in some cases improving other areas of their lives while mindfully seeking help to manage the risks of drug use (eg, needle exchange, naloxone, MAT, etc.), even as they continue their drug use. Harm reduction recognizes the harm that chaotic drug use coupled with ineffective drug policy can cause.

The opioid crisis and the willingness of the public and policymakers to consider new ideas to combat mortality and the spread of disease have propelled harm reduction toward an increasingly visible role in the public health debate. Moving forward, it will be critical for harm reduction to help move the conversation from an opioid-centric focus to one around drug policy as a whole. Though it is encouraging to see diverse groups come together to help resolve the issue of opioid-related disease and death, opioids will not always be the drug of choice. When that changes, public health professionals, policymakers, and communities need to be prepared to confront the next wave of drug-related harms, whether they be from the drugs themselves or from policies that make it harder for people to live healthy lives due to stigma, the effects of a criminal record, or difficulty accessing treatment and health care. How we handle the opioid epidemic will shape the debate on whether substance use is treated as a medical problem or a criminal one for decades to come. We need to all come together to advocate for evidence-based solutions to improve health and save lives across the state.

Acknowledgments

Potential conflict of interest. The author is an employee of the North Carolina Harm Reduction Coalition.

  • ©2018 by the North Carolina Institute of Medicine and The Duke Endowment. All rights reserved.

References

  1. ↵
    North Carolina Harm Reduction Coalition dataset. Accessed February 11, 2018.
  2. ↵
    1. North Carolina Harm Reduction Coalition
    US Law Enforcement Who Carry Naloxone. North Carolina Harm Reduction Coalition website. http://www.nchrc.org/law-enforcement/us-law-enforcement-who-carry-naloxone/. Accessed February 11, 2018.
  3. ↵
    1. North Carolina Department of Public Health and Human Services
    NC Pharmacies that Offer Naloxone Under a Standing Order. North Carolina Department of Public Health and Human Services website. http://www.naloxonesaves.org/n-c-pharmacies-that-offer-naloxone/. Accessed February 12, 2018.
  4. ↵
    1. Turner K,
    2. Hutchinson S,
    3. Vickerman P, et al.
    The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction. 2011;106(11):1978-1988.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Des Jarlais DC,
    2. Arasteh K,
    3. Friedman S R
    HIV among drug users at Beth Israel Medical Center, New York City, the first 25 years. Subst Use Misuse. 2011;46(2-3), 131-139.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Ksobiech K
    Return Rates for Needle Exchange Programs: A common criticism answered. Harm Reduct J. 2004;1(1):2.
    OpenUrlPubMed
  7. ↵
    1. Groseclose SL,
    2. Weinstein B,
    3. Jones TS,
    4. Valleroy LA,
    5. Fehrs LJ,
    6. Kassler WJ
    Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers—Connecticut, 1992-1993. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10(1):82-89.
    OpenUrlPubMed
  8. ↵
    1. Center for Innovative Public Policies
    Needle Exchange Programs: Is Baltimore a Bust? Tamarac, FL: Center for Innovative Public Policies; 2001. http://www.cipp.org/pdf/BALT_BUST.PDF. Accessed February 13, 2018.
  9. ↵
    1. Hagan H,
    2. McGough JP,
    3. Thiede H,
    4. Hopkins S,
    5. Duchin J,
    6. Alexander ER
    Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. J Subst Abuse Treat. 2000;19(3):247-252.
    OpenUrlCrossRefPubMed
  10. ↵
    1. North Carolina Department of Public Health and Human Services
    Syringe Exchange Programs in North Carolina. North Carolina Department of Public Health and Human Services website. https://www.ncdhhs.gov/divisions/public-health/north-carolina-safer-syringe-initiative/syringe-exchange-programs-north. Accessed February 12, 2018.
  11. ↵
    1. North Carolina Department of Health and Human Services, Division of Public Health, Injury and Violence Prevention Branch, Communicable Disease Branch
    North Carolina Safer Syringe Initiative. Raleigh, NC: North Carolina Department of Health and Human Services; 2017. http://www.injuryfreenc.ncdhhs.gov/DataSurveillance/NCSSI-2016-17-AnnualReportingSummary-SaferSyringeInitiative-v2.pdf. Accessed January 3, 2018.
  12. ↵
    1. Cruz H,
    2. Patra J,
    3. Fischer B,
    4. Rehm J,
    5. Kalousek K
    Public opinion Toward supervised injection facilities and heroin-assisted treatment in Ontario, Canada. Int. J Drug Policy. 2007;18(1):54-61.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

North Carolina Medical Journal: 79 (3)
North Carolina Medical Journal
Vol. 79, Issue 3
May-June 2018
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on North Carolina Medical Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Harm Reduction Strategies for the Opiod Crisis
(Your Name) has sent you a message from North Carolina Medical Journal
(Your Name) thought you would like to see the North Carolina Medical Journal web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
11 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Harm Reduction Strategies for the Opiod Crisis
Tessie Castillo
North Carolina Medical Journal May 2018, 79 (3) 192-194; DOI: 10.18043/ncm.79.3.192

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Harm Reduction Strategies for the Opiod Crisis
Tessie Castillo
North Carolina Medical Journal May 2018, 79 (3) 192-194; DOI: 10.18043/ncm.79.3.192
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Acknowledgments
    • References
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • The Opioid Epidemic in NC: Progress, Challenges, and Opportunities
  • Google Scholar

More in this TOC Section

Policy Forum

  • Breaking the Cycle
  • Breaking the Cycle
  • From Here to There—With a Spring in Our Steps
Show more Policy Forum

INVITED COMMENTARIES AND SIDEBARS

  • Sidebar: History Shaping the Future: How History Influences Health in North Carolina Native American Communities
  • Sidebar: Impact of Racial Misclassification of Health Data on American Indians in North Carolina
  • Sidebar: Community-driven Approaches to Preventing Overdoses Among American Indians
Show more INVITED COMMENTARIES AND SIDEBARS

Similar Articles

About & Contact

  • About the NCMJ
  • Editorial Board
  • Feedback

Info for

  • Advertisers
  • Authors
  • Reviewers
  • Subscribers

Articles & Alerts

  • Archive
  • Current Issue
  • Get Alerts
  • Upcoming Articles

Additional Content

  • Current NCIOM Task Forces
  • NC Health Data & Resources
  • NCIOM Blog
North Carolina Medical Journal

ISSN: 0029-2559

© 2022 North Carolina Medical Journal

Powered by HighWire